Where chronic lymphocytic leukaemia (CLL) presents with atypical morphology or a low white count and more malignant B cell non-Hodgkin's lymphomas (NHL) display blood and bone marrow dissemination, distinguishing these conditions morphologically and immunologically can be difficult. Since the prognosis and treatment are not the same a simple discriminatory test is potentially useful. 
Results
Twenty-two patients with CLL, eight with NHL and 31 controls were studied. The lymphocyte counts ranged from 285 x 109/l to 6-0 x 109/l in the CLL patients and from 74 x 109/l to 6-0 x 109/l in those with NHL. The mean, range and standard error of the proportion of mouse rosetting and coichicine sensitive lymphocytes in the groups studied are shown in the Table. It was found at an early stage that the percentage of cells dying in CLL or NHL plasma without the addition of colchicine was often very high (37-95 %), much higher than the control backgrounds. Incubating cells from nine of these patients (six CLL, three NHL) in both autologous plasma and fetal calf serum led to the discovery that in the latter, in all cases, the backgrounds were much lower (11-54 %) mostly within the normal range (5-24%). The difference between the results in the two types of supplement was highly significant (p < 0-001) indicating that patient's plasma had a lymphotoxic effect. Following this discovery all patient colchicine sensitivity cultures were incubated with fetal calf serum rather than autologous plasma as supplement. This cytotoxic effect was not seen in the control subjects.
Chronic lymphocytic leukaemia lymphocytes were ultrasensitive to colchicine at all three doses compared to the controls (p < 0-001), as were those from the NHL patients (p < 0-001). The two groups of patients did not differ significantly from each other, however (p > 0-1).
M rosette formation results did, on the other hand, show a difference (see Table) . While both the mean CLL value and the mean NHL values were significantly higher than the control value (p < 0-001, <0002 respectively), the NHL value was clearly significantly lower than the CLL value (p < 0-001 Mouse red cell rosette numbers in patients with CLL and NHL and normal controls.
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Colchicine sensitive cells in lymphomas other than CLL have been noted before25 and are thought to represent a fairly wide variety of immature, or abnormal, B cells.5 Normal B cells, however, are not apparently colchicine-sensitive, either those circulating5 or those in lymph nodes.6 Our own results would confirm that peripheral mixed normal lymphocytes are also resistant, and so the test may be helpful in distinguishing neoplastic from reactive lymphoproliferation.
M rosette formation, in contrast, appears to be a fairly specific feature of the CLL lymphocyte and has rarely been observed in other conditions. Exceptions include plasmacytomata, Waldenstr6m's macroglobulinaemia,7 and a proportion of patients with hairy cell leukaemia.8 As none of these disorders is likely to be confused with CLL if appropriate protein studies and cytochemistry are performed, they do not diminish the usefulness of the test. Ability to form M rosettes probably marks a fairly specific stage of B cell differentiation to which the CLL lymphocyte corresponds.
The lack of correlation between colchicinesensitive cells and M rosettes formed by our patients and their lymphocyte counts is not surprising as a similar lack of correlation has been previously noted39 and presumably simply reflects a variation in the number of normal lymphocytes present.
The incidental discovery of a cytotoxic effect of patients' plasma on their own cells is of more interest. Other workers have noted that CLL lymphocytes survive less well in cultures without colchicine than normal lymphocytes,5 9 and a nonantibody lymphotoxic factor in serum from a patient with CLL has been demonstrated using a cytotoxicity test.10 CLL serum has also been found to inhibit lymphocyte protein and nucleic acid synthesis induced by PHA,1112 but the nature and specificity of such inhibitory and cytotoxic activity, however, remains obscure at present. 
